Updated Jul 16, 2026
Bhowmick Neil is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Neil Bhowmick is the Chief Scientific Officer of Kairos Pharma Ltd (KAPA), a clinical-stage biopharmaceutical company focused on cancer therapeutics. In the SEC filing context, he is identified as the Chief Scientific Officer with no reported stock purchases or sales in the most recent filing dated 2025-12-30.
| Role | Chief Scientific Officer |
|---|---|
| Notability | 35/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-12-30 | KAPA | Kairos Pharma, LTD. | A — Grant or award | 171.8K | $0.00 |
Neil Bhowmick is the Chief Scientific Officer of Kairos Pharma Ltd (KAPA), a clinical-stage biopharmaceutical company focused on cancer therapeutics. In the SEC filing context, he is identified as the Chief Scientific Officer with no reported stock purchases or sales in the most recent filing dated 2025-12-30.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Bhowmick Neil profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.